Clinical trial Recruiting at 1 site Observational Ages 18 and up

Effects of Vitamin D on Dialysis Patients

Official title: Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management

Run by Medical University of Gdansk · NCT06571344 · Data updated 2026-11-12

This study is testing how taking vitamin D affects bone and mineral health in people on dialysis.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment160 (estimated)
SponsorMedical University of Gdansk
Academic / other
Locations1 site (Gdansk)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 26, 2024
Trial IDNCT06571344 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are dialysis patients with chronic kidney disease stage 5 who have vitamin D deficiency or insufficiency.

Probably not a fit

Patients who have been on dialysis for less than three months or those with inadequately controlled secondary hyperparathyroidism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate how cholecalciferol administration impacts laboratory parameters related to Chronic Kidney Disease-Mineral and Bone Disorder in dialysis patients. By analyzing medical records over a period of up to four years, the study will focus on the effects of vitamin D levels on calcium and phosphate metabolism. Participants will be monitored for changes in various biomarkers, including 25(OH)D, calcium, phosphates, and parathyroid hormone levels, to assess the efficacy and safety of vitamin D supplementation.

Why it matters

Potential benefit: If successful, this study could improve the management of vitamin D deficiency in dialysis patients, potentially enhancing their overall health outcomes.

How similar studies have gone: While there have been studies on vitamin D supplementation in various populations, this specific approach in dialysis patients is less explored, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* CKD stage 5,dialysed patients with vitamin D deficiency or insufficiency (level of 25(OH)D \< 30 ng/mL)

Exclusion Criteria:

* dialysis time of less than 3 months
* inadequately controled secondary hyperparathyroidism (iPTH\>800pg/mL)
* treatment with calcimimetics
* treatment with active forms of vitamin D3,
* parathyroidectomy
* bilateral nephrectomy
* treatment with corticosteroids
* lack of consent to take part in the study.

Where it's running

  • Medical University of Gdansk
    Gdansk, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.